ROFLUMILAST 500 MCG TABLET

Roflumilast
$0.3187per EA

Strength

500 ug/1

NDC

72205020030

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ROFLUMILAST

Approval Type

Generic (ANDA)

FDA Application

ANDA208256

On Market Since

9/7/2022

Pharmacological Classes

Phosphodiesterase 4 Inhibitor
Phosphodiesterase 4 Inhibitors

Price History

1W

0.0%

1M

+2.2%

3M

-5.3%

6M

+0.0%

1Y

-10.4%

3Y

-65.0%

5Y

N/A

All

-86.2%